- Home
- Publications
- Publication Search
- Publication Details
Title
Galectin-3: A Modifiable Risk Factor in Heart Failure
Authors
Keywords
Galectin-3, Biomarker, Heart failure, Cardiac remodeling, Fibrosis
Journal
CARDIOVASCULAR DRUGS AND THERAPY
Volume 28, Issue 3, Pages 237-246
Publisher
Springer Nature
Online
2014-05-01
DOI
10.1007/s10557-014-6520-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The ARCHITECT galectin-3 assay: comparison with other automated and manual assays for the measurement of circulating galectin-3 levels in heart failure
- (2014) Wouter C Meijers et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Prognostic Value of Changes in Galectin-3 Levels Over Time in Patients With Heart Failure
- (2013) A. Rogier van der Velde et al. Circulation-Heart Failure
- Galectin-3 in heart failure with preserved ejection fraction
- (2013) Rudolf A. de Boer et al. EUROPEAN JOURNAL OF HEART FAILURE
- Predictive value of serum galectin-3 levels in patients with acute heart failure with preserved ejection fraction
- (2013) Francisco Javier Carrasco-Sánchez et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Relationship Between Galectin-3 Levels and Mineralocorticoid Receptor Antagonist Use in Heart Failure: Analysis From HF-ACTION
- (2013) Mona Fiuzat et al. JOURNAL OF CARDIAC FAILURE
- Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis
- (2012) Laurent Calvier et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- RAAS Inhibitors and Cardiovascular Protection in Large Scale Trials
- (2012) Thomas G. von Lueder et al. CARDIOVASCULAR DRUGS AND THERAPY
- Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial Fibrogenesis
- (2012) Lili Yu et al. Circulation-Heart Failure
- Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure
- (2012) Dirk J. Lok et al. Clinical Research in Cardiology
- Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
- (2012) L. Gullestad et al. EUROPEAN HEART JOURNAL
- Why do drugs for acute heart failure fail?
- (2012) Adriaan A. Voors et al. EUROPEAN JOURNAL OF HEART FAILURE
- Aliskiren, ALTITUDE, and the implications for ATMOSPHERE
- (2012) John J.V. McMurray et al. EUROPEAN JOURNAL OF HEART FAILURE
- Galectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in the Community
- (2012) Jennifer E. Ho et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Usefulness of Plasma Galectin-3 Levels in Systolic Heart Failure to Predict Renal Insufficiency and Survival
- (2011) W.H. Wilson Tang et al. AMERICAN JOURNAL OF CARDIOLOGY
- Galectin-3 – A jack-of-all-trades in cancer
- (2011) Anna U. Newlaczyl et al. CANCER LETTERS
- Galectin-3 in Ambulatory Patients With Heart Failure
- (2011) G. Michael Felker et al. Circulation-Heart Failure
- Galectin-3 in heart failure: high levels are associated with all-cause mortality
- (2011) Thor Ueland et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The fibrosis marker galectin-3 and outcome in the general population
- (2011) R. A. de Boer et al. JOURNAL OF INTERNAL MEDICINE
- In search of new therapeutic targets and strategies for heart failure: recent advances in basic science
- (2011) Ajay M Shah et al. LANCET
- Modified Citrus Pectin Reduces Galectin-3 Expression and Disease Severity in Experimental Acute Kidney Injury
- (2011) Maria Kolatsi-Joannou et al. PLoS One
- Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
- (2010) Rudolf A. de Boer et al. ANNALS OF MEDICINE
- Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study
- (2010) Dirk J. A. Lok et al. Clinical Research in Cardiology
- Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure
- (2010) Ravi V. Shah et al. EUROPEAN JOURNAL OF HEART FAILURE
- Epidemiology and risk profile of heart failure
- (2010) Anh L. Bui et al. Nature Reviews Cardiology
- Galectin-3: a novel mediator of heart failure development and progression
- (2009) Rudolf A. de Boer et al. EUROPEAN JOURNAL OF HEART FAILURE
- The regulation of inflammation by galectin-3
- (2009) Neil C. Henderson et al. IMMUNOLOGICAL REVIEWS
- Myocardial remodeling after infarction: the role of myofibroblasts
- (2009) Susanne W. M. van den Borne et al. Nature Reviews Cardiology
- Galectin-3 Expression and Secretion Links Macrophages to the Promotion of Renal Fibrosis
- (2008) Neil C. Henderson et al. AMERICAN JOURNAL OF PATHOLOGY
- N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin
- (2008) Yun-He Liu et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- The immunological potential of galectin-1 and -3
- (2008) Amy Dhirapong et al. AUTOIMMUNITY REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation